folder E:21

First Page		Document Content
Date: 2006-06-21 08:10:24 Stem cells Emerging technologies Hematology Hematopoietic stem cell transplantation Surgical oncology Leukemia Gene therapy Acute leukemia Biology Medicine Biotechnology		folder E:21 Add to Reading List Source URL: www.leukemie.nl Download Document from Source Website File Size: 127,60 KB Share Document on Facebook

	The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2 DocID: 1uSbg - View Document
	A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan DocID: 1uJQ2 - View Document
	Vascular E-Selectin Mediates Chemo-Resistance in Acute Myeloid Leukemia Initiating Cells Via Canonical Receptors PSGL-1 (CD162) and Hcell (CD44) and AKT Signaling Ingrid G Winkler, PhD1, Johanna M Erbani, PhD student2, DocID: 1u5Xi - View Document
	Regulatory Perspective: Acute Leukemia Clinical Endpoints Nancy S. Scher, MD, FACP DODP, CDER, FDA 1 DocID: 1tdCV - View Document
	· ACUTE LYMPHOBL ASTIC LEUKEMIA · Incorporating Antibodies into Treatment Strategies for Acute Lymphoblastic Leukemia Nicholas J. Short, MD, and Elias Jabbour, MD DocID: 1shAS - View Document